Results 131 to 140 of about 199,076 (315)

Painful eye with a facial rash [PDF]

open access: bronze, 2009
José Luis Vallejo-García   +3 more
openalex   +1 more source

Adult female with rash and abdominal pain [PDF]

open access: gold, 2022
Landry Hadderton   +2 more
openalex   +1 more source

Neuroanatomical and functional correlates in borderline personality disorder: A narrative review

open access: yesIbrain, Volume 11, Issue 1, Page 19-31, Spring 2025.
Borderline personality disorder (BPD) is considered a dysfunctional, stable, and pervasive alteration in personality functioning with the inability to adapt to the environment, mental rigidity, and ego‐syntonic, and like all personality disorders is a consistent pattern of inner experience and behavior that deviates markedly from the expectations of ...
Giulio Perrotta
wiley   +1 more source

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu   +14 more
wiley   +1 more source

Measles Outbreak Associated with an Infectious Traveler - Colorado, May-June 2025. [PDF]

open access: yesMMWR Morb Mortal Wkly Rep
Metz AR   +14 more
europepmc   +1 more source

Ticked-Off Rash [PDF]

open access: hybrid
Rakin Solaiman   +3 more
openalex   +1 more source

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel   +21 more
wiley   +1 more source

Early recognition of the APECED rash can accelerate the diagnosis of APECED

open access: gold
Elise M. N. Ferré   +2 more
openalex   +1 more source

Mottled rash on the dorsal feet of an adolescent girl [PDF]

open access: hybrid
Kanya Rani Vashisht   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy